Should I buy Baker Hughes (BKR) stock or is it too late?
⭐ The most reliable of them, either direction: RBC Capital — 66% of its targets hit on this sector (161 calls tested). It aims for $76 (+35 %), call made on August 26, 2026, maturing on August 26, 2027 (49 d ago).
Firm-by-firm track record on Baker Hughes
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| RBC Capital | 91 % | +39.9 % | 11 | $76 +35% |
| Stifel | 100 % | +35.1 % | 7 | $75 +33% |
| Piper Sandler | 80 % | +34.3 % | 10 | $73 +29% |
| JP Morgan | 100 % | +33.2 % | 6 | $74 +31% |
| Evercore ISI Group | 88 % | +30.1 % | 8 | $76 +35% |
| Citigroup | 62 % | +24.7 % | 16 | $75 +33% |
| Barclays | 75 % | +24.0 % | 24 | $72 +28% |
| Susquehanna | 79 % | +20.9 % | 14 | $75 +33% |
✅ Reasons to believe
- 83% of analysts rate it a buy (Buy consensus, 12 ratings) — a sign of market conviction.
- Median price target $75, i.e. +33% from the current price ($56).
- The most reliable firm on BKR, Stifel (100% hit rate, 7 scored calls), targets $75 (call made on July 28, 2026, maturing on July 28, 2027) (+33%) in its most recent call, and $57 (call made on January 21, 2026, maturing on January 21, 2027) (+1%) in the one coming due soonest.
- Pays a dividend (1.7% yield) — regular income on top of potential upside.
- Reasonable valuation (P/E ~18) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 12 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
The analyst consensus on BKR
Median target $75 (+33%) · 12 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Baker Hughes now?
We won't decide for you. The facts: 83% of analysts rate it a buy, median target $75 (+33%), and Stifel (most reliable on BKR, 100%) targets $75. Weigh that against valuation (P/E ~18) and volatility. This is not personalized advice.
Is it too late to invest in Baker Hughes?
Not according to analysts: the median target ($75) is still +33% above the current price ($56) (most reliable on BKR: Stifel, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Baker Hughes still worth investing in?
It depends on the gap between the price ($56) and its estimated value: analysts target $75 on median (+33%), with 83% buys (most reliable on BKR: Stifel, 100%). Cross-check with their real reliability on BKR and the cautions above. Information, not advice.
What's the main risk in buying BKR?
The consensus is not unanimous: of 12 ratings, 2 are neutral.
→ Go deeper: the full Baker Hughes profile (consensus, analyst reliability, price target, performance).